GENE ONLINE|News &
Opinion
Blog

m&a
Investment Trends & Forecasts
[Illustrations] Selective Capital, Targeted Deals, and a Tightened Public-Market Bar: How 2026 Is Shaping M&A and IPOs
2026-02-09
Trials & Approvals Alzheimer's Drug
Leqembi Makes History as First EU-Approved Drug to Target Root Cause of Alzheimer’s Disease
2025-04-15
JPM 2025 Key Insights
Looking at the Bigger Picture: 5 Key Takeaways from JPM 2025
2025-01-23
JPM 2025 M&A 2025
EY Predicts Smarter, Smaller M&A in Biotech and Pharma for 2025
2025-01-15
Biotech Giants Behind Partnerships in Precision Therapies, Gene Editing, and ADCs
2025-01-03
2024
The Boldest Business Matchmaking of 2024: A Look at the Top M&A Activity
2025-01-02
Startup
Health Innovations Acquires a Singapore-based Startup, Strengthening Digital Healthcare
2023-09-11
LATEST
Health Insurers Adopt Wearable Data Tracking Models Similar to Automotive Telematics
2026-08-14
Biogen’s Alzheimer’s Tau Drug Splits Experts: Can Diranersen Challenge Leqembi?
2026-08-14
Definium’s Psychedelic Anxiety Drug DT120 Moves Closer to the Mainstream With a Phase 3 Win
2026-08-14
JAMA Network Open Study Links Agent Orange and Burn Pit Exposure to Veteran Health Outcomes
2026-08-14
La Mojana Earthworks Reveal Long-Term Sustainable Water Management by Pre-Hispanic Societies
2026-08-13
Grant Evaluators Divided Over Prioritizing Past Performance Versus Future Potential
2026-08-13
UC Riverside Study Finds High-Intensity Running Does Not Reduce Lifespan in Mice
2026-08-13
READ MORE
EVENT
2026-09-02
BIO Asia Pacific (APAC Biotech & Smart Health)
Bangkok, Thailand
2026-09-16
BIOHK (16–19, Hong Kong) (Hong Kong biotech & investment)
Hong Kong
2026-10-07
BioJapan / HealthTECH JAPAN (Biotech, Medtech, Regenerative)
Yokohama, Japan
2026-10-07
Hospital Expo Tokyo (Devices & Hospital IT)
Tokyo, Japan
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
2026-10-23
ESMO Congress 2026 (Oncology Breakthroughs)
Madrid, Spain
SEE MORE
Scroll to Top